Drug Promotion: M&A, Old Social Media Posts Can Increase Risk Of US FDA Enforcement

 
• By Sue Sutter

The loss of institutional knowledge about OPDP’s prior comments on promotional materials can result in an enforcement letter for the new owner of a company or product, experts say.

Elephant in the room
Like an elephant, the FDA never forgets what it tells sponsors about their promotional campaigns. (Shutterstock)

More from Marketing & Advertising

More from FDLI